HIV molecular immunology database
Found 1 matching record:
HXB2 Location | Gag(151-159) | Gag Epitope Map
View variants at this location |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Epitope |
TLNAWVKVV
|
Epitope Alignment | |||||||||||||
Variants |
|
||||||||||||||
Species (MHC/HLA) | human(A*02:01) |
Showing all: 4 variant(s).
Variant ID. | 3378 |
---|---|
Epitope Seq. | TLNAWVKVV |
Variant Seq. | TLDAWVKVV |
Mutations | N/D |
Epitope Location | N3D |
HXB2 Location | N153D |
Mutation Type | SF: susceptible form |
Epitope Subtype | B |
Variant Subtype | B |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | First variant to arise; seen in early and late post-seroconversion periods; positive Elispot <100 SFC/106PBMC in early post-SC, and <50 SFC/106PBMC in late post-SC period. |
Variant ID. | 3379 |
---|---|
Epitope Seq. | TLNAWVKVV |
Variant Seq. | ALNAWVKVV |
Mutations | T/A |
Epitope Location | T1A |
HXB2 Location | T151A |
Mutation Type | SF: susceptible form |
Epitope Subtype | B |
Variant Subtype | B |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | Second variant to arise; seen in early and late post-seroconversion periods; positive Elispot response <100 SFC/106PBMC in early period, but negative in late period. |
Variant ID. | 3380 |
---|---|
Epitope Seq. | TLNAWVKVV |
Variant Seq. | PLNAWVKVV |
Mutations | T/P |
Epitope Location | T1P |
HXB2 Location | T151P |
Mutation Type | SF: susceptible form |
Epitope Subtype | B |
Variant Subtype | B |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | Third variant to arise; seen in early and late ART periods; positive Elispot >600 SFC/106PBMC in early ART, and 100-200 SFC/106PBMC in late ART period. |
Variant ID. | 3381 |
---|---|
Epitope Seq. | TLNAWVKVV |
Variant Seq. | TLSAWVKVV |
Mutations | N/S |
Epitope Location | N3S |
HXB2 Location | N153S |
Mutation Type | SF: susceptible form |
Epitope Subtype | B |
Variant Subtype | B |
Method | CD8 T-cell Elispot - IFNy, Sequence |
Note | Fourth variant to arise; seen in early and late ART periods; positive Elispot about 300 SFC/106PBMC in early ART, and 100-200 SFC/106PBMC in late ART period. |
Melhem2014 Nada M Melhem, Kellie N. Smith, Xiao-Li Huang, Bonnie A Colleton, Weimin Jiang, Robbie B. Mailliard, James I. Mullins, and Charles R. Rinaldo. The Impact of Viral Evolution and Frequency of Variant Epitopes on Primary and Memory Human Immunodeficiency Virus Type 1-Specific CD8+ T Cell Responses. Virology, 450-451:34-48, Feb 2014. PubMed ID: 24503065. Show all entries for this paper.